January 21, 2026 – The Japan Pharmaceutical Manufacturers Association (JPMA) has joined forces with INCATE (INCubator for Antimicrobial Therapies in Europe), strengthening global collaboration to support innovation and solutions against antimicrobial resistance (AMR). INCATE brings [...]
More news
February 2024 – Xiretsa, Inc is the second selected venture to receive INCATEs Stage II [...]
Do you have an outstanding antimicrobial resistance (AMR) innovation that you would like to share [...]
After receiving over 40 applications and going through a rigorous decision process, the finalists for [...]
As December arrives and 2023 draws to a close, it's time for reflection. The statistics [...]
December 6th 2023 – INCATE (the INCubator for Antibacterial Therapies in Europe) and Kineticos AMR [...]
The INCATE Selection Committee selected the last 4 new ventures for Stage I support in [...]
On November 8th 2023 we organized INCATEs 3rd Entrepreneurs Club about ways to get funding [...]
Innovate UK, LifeArc, and Medicines Discovery Catapult (MDC) have joined forces to create PACE (Pathways [...]
